
-
'Skibidi' and 'tradwife': social media words added to Cambridge dictionary
-
Akie Iwai joins twin sister Chisato as LPGA winner with Portland Classic triumph
-
LIV's DeChambeau joins Henley and English as US Ryder Cup qualifiers
-
No.1 Scheffler outlasts MacIntyre to win BMW Championship
-
Swiatek swamps Rybakina, to face Paolini in Cincinnati final
-
Atletico beaten by Espanyol in La Liga opener
-
PSG get Ligue 1 title defence off to winning start
-
Rahm edges Niemann for LIV season title as Munoz wins at Indy
-
Seven killed in latest Ecuador pool hall shooting
-
Mass rally in Tel Aviv calls for end to Gaza war, hostage deal
-
Terence Stamp: from arthouse icon to blockbuster villain
-
World No. 3 Swiatek powers past Rybakina into Cincinnati WTA final
-
Tens of thousands of Israelis protest for end to Gaza war
-
Terence Stamp, 60s icon and Superman villain, dies
-
Air Canada suspends plan to resume flights as union vows to continue strike
-
Arsenal battle to beat Man Utd, world champions Chelsea held by Palace
-
Arsenal capitalise on Bayindir error to beat Man Utd
-
'Weapons' tops North American box office for 2nd week
-
Newcastle sign Ramsey from Aston Villa
-
Terence Stamp in five films
-
Terence Stamp, Superman villain and 'swinging sixties' icon, dies aged 87: UK media
-
Chelsea draw blank in Palace stalemate
-
European leaders to join Zelensky in Trump meeting
-
Hopes for survivors wane after Pakistan flooding kills hundreds
-
Six in a row for Marc Marquez with victory at Austrian MotoGP
-
Spain PM vows 'climate pact' on visit to fire-hit region
-
Serbia's president vows 'strong response' after days of unrest
-
Brazilian goalkeeper Fabio equals Shilton record for most games played
-
Warholm in confident swagger towards Tokyo worlds
-
Air Canada to resume flights after govt directive ends strike
-
European leaders to join Zelensky in US for Ukraine talks with Trump
-
Israelis rally nationwide calling for end to Gaza war, hostage deal
-
European leaders to join Zelensky for Ukraine talks with Trump
-
Downgraded Hurricane Erin lashes Caribbean with rain
-
Protests held across Israel calling for end to Gaza war, hostage deal
-
Hopes for survivors wane as landslides, flooding bury Pakistan villages
-
After deadly protests, Kenya's Ruto seeks football distraction
-
Bolivian right eyes return in elections marked by economic crisis
-
Drought, dams and diplomacy: Afghanistan's water crisis goes regional
-
'Pickypockets!' vigilante pairs with social media on London streets
-
From drought to floods, water extremes drive displacement in Afghanistan
-
Air Canada flights grounded as government intervenes in strike
-
Women bear brunt of Afghanistan's water scarcity
-
Reserve Messi scores in Miami win while Son gets first MLS win
-
Japan's Iwai grabs lead at LPGA Portland Classic
-
Trump gives Putin 'peace letter' from wife Melania
-
Alcaraz to face defending champ Sinner in Cincinnati ATP final
-
Former pro-democracy Hong Kong lawmaker granted asylum in Australia
-
SEG Announces 2025 Interim Results
-
President Trump's Marijuana Fix? DEA’s Program Exposed: Promises Made, Promises Not Kept

Ozempic slimming craze sweeps Kosovo despite side effects
Kosovo influencer Tringa Kadriu sees the slimming drug Ozempic as a chance to shed excess pounds -- and she is not the only one in her Balkan nation, where more than half the population is overweight.
"I want to lose 15-16 kilos (33-35 pounds) in two months," Kadriu, 29, told AFP, "and then I'll continue with fitness".
Ozempic, approved in the United States to treat diabetes in 2017, has found an international market for people trying to lose weight.
Despite its cost, the drug has soared in popularity in Kosovo, a country of 1.7 million.
While Kosovo authorities have not sanctioned the drug's use for weight loss, they have noted their limited means to confront use of a drug widely available in the country.
Merita Emini-Sadiku, who heads the Kosovo university hospital's endocrinology clinic, said the cost of the drug had soared.
"The monthly dose used to be 75-80 euros ($85-91), while now it is 130-140 euros ($147-159), probably due to high demand," she said.
But she warned that "Ozempic has side effects that people are not aware of".
Ozempic use can potentially cause issues including thyroid cancer, pancreatitis, gastroparesis and bowel obstruction, according to the latest studies.
- 'Constant demand' -
Meant to treat Type 2 diabetes -- of which the WHO says Kosovo has lower than average levels -- the drug regulates blood sugar levels but also helps suppress hunger, leading to a lower calorie intake.
As a result, its potentially cancerous complications have done little to stem the drug's popularity or availability.
"I checked a lot of pharmacies in Kosovo and I noticed that Ozempic is very easy to get," said Kadriu, adding that pharmacists even suggested she gradually increase her dosage.
A worker at a pharmacy in the capital Pristina's downtown, who asked to remain anonymous, said she had trouble recalling when someone last came into her pharmacy to buy Ozempic with a diabetes prescription.
"But we have a constant demand for Ozempic without a prescription. You can guess why," she said.
Given its availability, Emini-Sadiku said authorities should exercise greater control over Ozempic's distribution.
But Bujar Vitija, a journalist specialising in health, said that would be tricky to achieve given Kosovo's poor health record-keeping.
"Unfortunately there is no data," Vitija said.
With 1,500 to 1,600 private pharmacies in Kosovo, the country's 20 pharmaceutical inspectors have their work cut out for them, he added.
- Ozempic 'every day' -
While Kosovo has lower levels of obesity than the European average, more than 57 percent of the population is overweight and 20 percent is clinically obese, according to a 2019 World Health Organization report.
And women, who are more likely to face societal pressure to be thin, were 66 percent more likely to be obese than men, the WHO report found.
But not every Kosovar who has used Ozempic had the best experience with the drug.
"I took Ozempic on the advice of a doctor for two years but it had no effect," said 48-year-old merchant Lulzim Rrahmani, adding that three of his relatives even experienced "a negative effect of the drug".
"It was just a waste of money and time."
Given the risk of side effects, Emini-Sadiku said Ozempic was "by no means to be taken without a doctor's prescription".
Yet Kadriu said she would not be deterred, adding that she saw colleagues taking the drug "every day at work".
"I don't see any symptom that would deter me."
F.Dubois--AMWN